Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...
Pune, July 05, 2024 (GLOBE NEWSWIRE) -- Active Pharmaceutical Ingredient Market Analysis: "According to SNS Insider Research, The Active Pharmaceutical Ingredient Market is valued at USD 239.45 ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Irish manufacturer brings commercial-scale, EU GMP-certified production and reliable supply to medicines produced through the ...
Hyderabad, Aug 5 (PTI) Gland Pharma and Neuland Laboratories on Wednesday announced a long-term strategic contract ...
C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...
ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
HPAPI manufacturing takes more than containment—it requires a partner that can manage scale-up, tech transfer and future ...
(MENAFN- GlobeNewsWire - Nasdaq) The Global API market is expanding due to rising chronic diseases, demand for generics post-patent expirations, and R&D investments. There are opportunities in ...
Vietnam Investment Review on MSN
Piramal Pharma expands peptide API facility with spray drying
MUMBAI, India, Aug. 4, 2026 /PRNewswire/ -- Piramal Pharma Solutions ("PPS"), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results